• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Safety implications of the over-the-counter availability of H2-antagonists.

作者信息

Andersen M, Schou J S

机构信息

Department of Pharmacology, University of Copenhagen, Denmark.

出版信息

Drug Saf. 1993 Mar;8(3):179-85. doi: 10.2165/00002018-199308030-00001.

DOI:10.2165/00002018-199308030-00001
PMID:8095787
Abstract
摘要

相似文献

1
Safety implications of the over-the-counter availability of H2-antagonists.H2拮抗剂非处方可得的安全性影响。
Drug Saf. 1993 Mar;8(3):179-85. doi: 10.2165/00002018-199308030-00001.
2
Adverse reactions to H2-receptor antagonists in Denmark before and after transfer of cimetidine and ranitidine to over-the-counter status.西咪替丁和雷尼替丁转为非处方药状态前后丹麦对H2受体拮抗剂的不良反应。
Pharmacol Toxicol. 1991 Oct;69(4):253-8. doi: 10.1111/bcpt.1991.69.4.253.
3
[Over-the-counter drugs, subsidy and safety].
Ugeskr Laeger. 1991 May 13;153(20):1401-2.
4
Pros and cons of over-the-counter availability of histamine2-receptor antagonists.
Arch Intern Med. 1993 Nov 8;153(21):2415-24.
5
[Adverse effects of ulcer drugs before and after release of cimetidine, ranitidine and sucralfate for over-the-counter sale].[西咪替丁、雷尼替丁和硫糖铝非处方药上市前后溃疡药物的不良反应]
Ugeskr Laeger. 1991 May 13;153(20):1410-3.
6
Do OTC 'ulcer drugs' pose problems when used with dental medications?非处方“溃疡药”与牙科药物一起使用时会产生问题吗？
RDH. 1995 Dec;15(12):25, 39.
7
Habit, prejudice, power and politics: issues in the conversion of H2-receptor antagonists to over-the-counter use.习惯、偏见、权力与政治：H2受体拮抗剂转为非处方药使用中的问题。
CMAJ. 1996 Jan 1;154(1):49-53.
8
Drug interactions between prescribed and over-the-counter medication.处方药与非处方药之间的药物相互作用。
Drug Saf. 1995 Nov;13(5):296-303. doi: 10.2165/00002018-199513050-00003.
9
Over-the-counter H2-receptor antagonists for heartburn.
Med Lett Drugs Ther. 1995 Oct 27;37(960):95-6.
10
The drug interactions we all overlook.我们都忽视的药物相互作用。
RN. 1981 Feb;44(2):37-41.

引用本文的文献

1
Benefits and risks of self medication.自我药疗的益处与风险。
Drug Saf. 2001;24(14):1027-37. doi: 10.2165/00002018-200124140-00002.
2
Switching the histamine H2 receptor antagonist famotidine to nonprescription status in Canada. An economic evaluation.在加拿大将组胺H2受体拮抗剂法莫替丁转为非处方药状态：一项经济学评估。
Pharmacoeconomics. 1996 Jan;9(1):61-75. doi: 10.2165/00019053-199609010-00007.
3
Formulary management of drugs for cancer-associated hypercalcaemia.癌症相关性高钙血症用药的处方集管理

本文引用的文献

1
Long-term follow-up study of cimetidine.西咪替丁的长期随访研究。
Pharmacotherapy. 1984 Nov-Dec;4(6):381-4. doi: 10.1002/j.1875-9114.1984.tb03400.x.
2
A unique postmarket outpatient surveillance program of cimetidine: report on phase II and final summary.西咪替丁独特的上市后门诊监测项目：II期报告及最终总结
Am J Gastroenterol. 1984 Aug;79(8):593-6.
3
Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up.西咪替丁安全性的上市后监测：随访第二、三、四年期间的死亡率
Pharmacoeconomics. 1996 Jan;9(1):39-50. doi: 10.2165/00019053-199609010-00005.
4
Ranitidine: a pharmacoeconomic evaluation of its use in acid-related disorders.雷尼替丁：对其在酸相关性疾病治疗中应用的药物经济学评价
Pharmacoeconomics. 1994 Jul;6(1):57-89. doi: 10.2165/00019053-199406010-00007.
5
Habit, prejudice, power and politics: issues in the conversion of H2-receptor antagonists to over-the-counter use.习惯、偏见、权力与政治：H2受体拮抗剂转为非处方药使用中的问题。
CMAJ. 1996 Jan 1;154(1):49-53.
6
Polypharmacy. Pharmacokinetic perspectives.多重用药。药代动力学视角。
Clin Pharmacokinet. 1994 Feb;26(2):85-90. doi: 10.2165/00003088-199426020-00001.
7
Are H2 receptor antagonists safe over the counter drugs?H2受体拮抗剂是非处方药吗？它们安全吗？
BMJ. 1994;309(6953):493-4. doi: 10.1136/bmj.309.6953.493.
8
Over-the-counter histamine H2-receptor antagonists. How will they affect the treatment of acid-related diseases?非处方组胺H2受体拮抗剂。它们将如何影响酸相关性疾病的治疗？
Drugs. 1994 Jan;47(1):1-11. doi: 10.2165/00003495-199447010-00001.
Br Med J (Clin Res Ed). 1985 Oct 19;291(6502):1084-8. doi: 10.1136/bmj.291.6502.1084.
4
Endoscopy in the evaluation of dyspepsia. Health and Public Policy Committee, American College of Physicians.消化不良评估中的内镜检查。美国医师协会健康与公共政策委员会
Ann Intern Med. 1985 Feb;102(2):266-9.
5
Cimetidine toxicity: an assessment of 881 cases.西咪替丁毒性：881例病例评估
Ann Emerg Med. 1987 Nov;16(11):1217-21. doi: 10.1016/s0196-0644(87)80226-3.
6
Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia.抗酸剂或西咪替丁对非溃疡性消化不良无治疗益处。
N Engl J Med. 1986 Feb 6;314(6):339-43. doi: 10.1056/NEJM198602063140603.
7
Gastric cancer--delay in diagnosis and its causes.胃癌——诊断延误及其原因
Eur J Cancer Clin Oncol. 1987 Nov;23(11):1683-90. doi: 10.1016/0277-5379(87)90450-0.
8
[Basis for ulcus therapy in general practice].
Ugeskr Laeger. 1988 Sep 12;150(37):2169-71.
9
Ranitidine versus cimetidine. A comparison of their potential to cause clinically important drug interactions.雷尼替丁与西咪替丁。二者引发具有临床重要性药物相互作用可能性的比较。
Clin Pharmacokinet. 1988 Jul;15(1):44-56. doi: 10.2165/00003088-198815010-00004.
10
Over the counter sales of histamine-2 receptor antagonists.组胺-2受体拮抗剂的非处方销售。
Scand J Gastroenterol Suppl. 1988;155:20-2. doi: 10.3109/00365528809096276.